.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Betamethasone - Generic Drug Details

« Back to Dashboard
Betamethasone is the generic ingredient in twenty-four branded drugs marketed by Merck Sharp Dohme, Schering, Luitpold, Parke Davis, Tolmar, Actavis Mid Atlantic, Taro, Fougera Pharms, Perrigo New York, Glenmark Generics, Pharmaderm, Savage Labs, Fougera, G And W Labs Inc, Teva, Promius Pharma Llc, Alpharma Us Pharms, Leo Pharma As, Perrigo Israel, Glenmark Pharms, Watson Labs, Delcor Asset Corp, Perrigo, Roaco, Sti Pharma Llc, Teva Pharms, and Pharmafair, and is included in one hundred NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone. There is one tentative approval for this compound.

Summary for Generic Name: betamethasone

Tradenames:24
Patents:8
Applicants:27
NDAs:100
Drug Master File Entries: see list66
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices

Tentative approvals for BETAMETHASONE

Applicant Application No. Form Dosage
<disabled><disabled>FOAM;TOPICAL0.12%
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
DIPROSONE
betamethasone dipropionate
LOTION;TOPICAL017781-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Taro
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
OINTMENT, AUGMENTED;TOPICAL076753-001Oct 12, 2004RXNo► subscribe► subscribe
Fougera
BETAMETHASONE VALERATE
betamethasone valerate
CREAM;TOPICAL018861-001Aug 31, 1983RXYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
CELESTONE
betamethasone
SYRUP;ORAL014215-002Approved Prior to Jan 1, 19823,485,854► subscribe
Schering
CELESTONE
betamethasone
CREAM;TOPICAL014762-001Approved Prior to Jan 1, 19823,485,854► subscribe
Schering
CELESTONE
betamethasone
TABLET;ORAL012657-003Approved Prior to Jan 1, 19823,485,854► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc